Verve Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $256k | 45k | 5.64 |
| 2024-09-30 | $176k | 36k | 4.84 |
| 2024-06-30 | $171k | 35k | 4.88 |
| 2024-03-31 | $358k | 27k | 13.28 |
| 2023-12-31 | $231k | 17k | 13.94 |
| 2023-09-30 | $846k | 64k | 13.26 |
| 2023-06-30 | $1.1M | 61k | 18.75 |
| 2022-12-31 | $50k | 2.6k | 19.35 |
| 2022-09-30 | $237k | 6.6k | 35.90 |
| 2022-06-30 | $10k | 581 | 17.14 |
| 2022-03-31 | $94k | 4.1k | 22.70 |
| 2021-12-31 | $170k | 4.6k | 36.83 |
| 2021-09-30 | $4.0k | 79 | 50.63 |
| 2021-06-30 | $6.0k | 100 | 60.00 |